AIM: To assess and promote compliance of Italian cardiological intensive care units (CCUs) with evidence-based guidelines for the management of acute myocardial infarction (MI). METHODS AND RESULTS: The process of diagnosis and treatment of MI was prospectively evaluated in 163 CCUs by use of 30 indicators during two enrolment phases, each followed by a feedback of both local and general performance. Overall, 5854 patients with ST-segment elevation MI (STEMI) and 5852 with non-ST-segment elevation MI (NSTEMI) were consecutively enrolled. The target for each indicator was defined as compliance with the relevant recommendations in ≥90% of suitable patients and it was met for nine (30%) and 10 (33.3%) indicators in the first and second phases, respectively. Regardless of target, a significant improvement in compliance was observed in the second phase in 10 out of 30 indicators (33.3%). Use of pre-hospital ECG, expedite delivery of reperfusion therapy, dosage of antithrombotic drugs, and non-pharmacological implementation of secondary prevention were often off target. Similar in-hospital mortality was observed in phases I and II, both in patients with STEMI (4.0 vs. 4.2%, p=0.79) and NSTEMI (1.8 vs. 2.4%, p=0.11). Overall, 30-day mortality were 5.7% for patients with STEMI and 3.4% with NSTEMI. CONCLUSIONS: Performance indicators can accurately weigh the whole process of diagnosis and treatment of patients with MI and monitor the improvements in the quality of care. In our large population of consecutive patients, satisfactory 30-day outcomes were observed despite suboptimal adherence to guidelines for some indicators of recognised prognostic relevance.
AIM: To assess and promote compliance of Italian cardiological intensive care units (CCUs) with evidence-based guidelines for the management of acute myocardial infarction (MI). METHODS AND RESULTS: The process of diagnosis and treatment of MI was prospectively evaluated in 163 CCUs by use of 30 indicators during two enrolment phases, each followed by a feedback of both local and general performance. Overall, 5854 patients with ST-segment elevation MI (STEMI) and 5852 with non-ST-segment elevation MI (NSTEMI) were consecutively enrolled. The target for each indicator was defined as compliance with the relevant recommendations in ≥90% of suitable patients and it was met for nine (30%) and 10 (33.3%) indicators in the first and second phases, respectively. Regardless of target, a significant improvement in compliance was observed in the second phase in 10 out of 30 indicators (33.3%). Use of pre-hospital ECG, expedite delivery of reperfusion therapy, dosage of antithrombotic drugs, and non-pharmacological implementation of secondary prevention were often off target. Similar in-hospital mortality was observed in phases I and II, both in patients with STEMI (4.0 vs. 4.2%, p=0.79) and NSTEMI (1.8 vs. 2.4%, p=0.11). Overall, 30-day mortality were 5.7% for patients with STEMI and 3.4% with NSTEMI. CONCLUSIONS: Performance indicators can accurately weigh the whole process of diagnosis and treatment of patients with MI and monitor the improvements in the quality of care. In our large population of consecutive patients, satisfactory 30-day outcomes were observed despite suboptimal adherence to guidelines for some indicators of recognised prognostic relevance.
Authors: Jean-Pierre Bassand; Christian W Hamm; Diego Ardissino; Eric Boersma; Andrzej Budaj; Francisco Fernández-Avilés; Keith A A Fox; David Hasdai; E Magnus Ohman; Lars Wallentin; William Wijns Journal: Eur Heart J Date: 2007-06-14 Impact factor: 29.983
Authors: Shamir R Mehta; Christopher P Cannon; Keith A A Fox; Lars Wallentin; William E Boden; Rudolf Spacek; Petr Widimsky; Peter A McCullough; David Hunt; Eugene Braunwald; Salim Yusuf Journal: JAMA Date: 2005-06-15 Impact factor: 56.272
Authors: Harlan M Krumholz; Jeffrey L Anderson; Brian L Bachelder; Francis M Fesmire; Stephan D Fihn; JoAnne M Foody; P Michael Ho; Mikhail N Kosiborod; Frederick A Masoudi; Brahmajee K Nallamothu Journal: J Am Coll Cardiol Date: 2008-12-09 Impact factor: 24.094
Authors: Andra L Blomkalns; Matthew T Roe; Eric D Peterson; E Magnus Ohman; Elizabeth S Fraulo; W Brian Gibler Journal: Acad Emerg Med Date: 2007-11 Impact factor: 3.451
Authors: Leonardo De Luca; Zoran Olivari; Leonardo Bolognese; Donata Lucci; Lucio Gonzini; Antonio Di Chiara; Gianni Casella; Francesco Chiarella; Alessandro Boccanelli; Giuseppe Di Pasquale; Francesco M Bovenzi; Stefano Savonitto Journal: Open Heart Date: 2014-12-13
Authors: Leonardo De Luca; Marco Marini; Lucio Gonzini; Alessandro Boccanelli; Gianni Casella; Francesco Chiarella; Stefano De Servi; Antonio Di Chiara; Giuseppe Di Pasquale; Zoran Olivari; Giorgio Caretta; Laura Lenatti; Michele Massimo Gulizia; Stefano Savonitto Journal: J Am Heart Assoc Date: 2016-11-23 Impact factor: 5.501
Authors: Sergio Leonardi; Claudio Montalto; Gianni Casella; Daniele Grosseto; Alessandra Repetto; Monica Portolan; Federico Fortuni; Filippo Ottani; Marcello Galvani; Laura Sofia Cardelli; Stefano De Servi; Andrea Rubboli; Gaetano Maria De Ferrari; Luigi Oltrona Visconti; Gianluca Campo Journal: Open Heart Date: 2020-12
Authors: Mauro Giovanni Carta; Federica Sancassiani; Davide Bina; Marco Licciardi; Giulia Cossu; Antonio Egidio Nardi; Luigi Meloni; Roberta Montisci Journal: J Public Health Res Date: 2022-03-16